Cancer Risk Factors in SLE: Multivariate Regression Analysis in 16,409 Patients
DOI:
https://doi.org/10.12970/2310-9874.2014.02.03.4Keywords:
Cancer, systemic lupus erythematosus.Abstract
Background: We assessed factors associated with cancer risk in systemic lupus erythematosus (SLE), relative to the general population, using a large international multi-centre clinical cohort (30 centres, 16,409 patients).
Methods: Cancers were ascertained by registry linkage. We used Poisson hierarchical regression to assess for potential independent effects of sex, race/ethnicity, age group, SLE duration, and calendar-year period on the standardized incidence ratios (SIR; ratio of cancers observed to expected). The hierarchical model allowed for differences in effects across countries. The primary regression analyses were done using the overall cancer SIRs; in secondary analyses we focused on hematological cancer SIRs.
Results: In adjusted analyses, we demonstrated lower SIR estimates for overall cancer risk, in black versus white SLE patients, in SLE patients of older versus younger age, and for patients with SLE duration of 5 years or more (versus lower duration). Female sex and calendar year were not clearly associated. Regarding hematological cancers specifically, SLE duration of 5 years or more again appeared to be associated with lower SIR estimates.
Conclusion: Cancer risk in SLE is increased relative to the general population; this is particularly true for patients of white race/ethnicity, younger age, and of shorter SLE duration.
References
Parikh-Patel A, White RH, Allen M, Cress R. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control 2008; 19(8): 887-94. http://dx.doi.org/10.1007/s10552-008-9151-8
Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40(4): 761-8. http://dx.doi.org/10.1002/art.1780400424
Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31(2): 66-71. http://dx.doi.org/10.1080/03009740252937568
Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 2013; 42: 130-5. http://dx.doi.org/10.1016/j.jaut.2012.12.009
Bernatsky SR, Cooper GS, Mill C, Ramsey-Goldman R, Clarke AE, Pineau CA. Cancer screening in patients with systemic lupus erythematosus. J Rheumatol 2006; 33(1): 45-9.
Bernatsky S, Boivin J, Lawrence J, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis & Rheumatism 2005; 52(5): 1481-90. http://dx.doi.org/10.1002/art.21029
Bernatsky S, Ramsey-Goldman R, Silverman ED, et al. Cancer Risk In Pediatric Systemic Lupus: Updated Analyses. Arthr Rheum 2011; 62(Suppl), S18583.